New York, Nov. 18 – JPMorgan Chase Financial Co. LLC priced $5.84 million of callable contingent interest notes due Sept. 26, 2025 linked to the S&P 500 index and the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.
Investors will receive a coupon of 15% per year, payable semiannually, if each asset closes at or above its 60% downside threshold on the relevant determination date.
The securities may be called at par on any semiannual determination date.
If the worst performing asset finishes at or above its 60% downside threshold, the payout at maturity will be par plus the coupon.
Otherwise, investors will lose 1% for every 1% that the worst performing asset declines from initial level.
The notes are guaranteed by JPMorgan Chase & Co.
J.P. Morgan Securities LLC is the agent.
| Issuer: | JPMorgan Chase Financial Co. LLC
|
| Guarantor: | JPMorgan Chase & Co.
|
| Issue: | Callable contingent interest notes
|
| Underlying assets: | S&P 500 index and SPDR S&P Biotech ETF
|
| Amount: | $5,838,000
|
| Maturity: | Sept. 26, 2025
|
| Coupon: | 15% per year, payable semiannually if each asset closes at or above downside threshold on the relevant determination date
|
| Price: | Par
|
| Payout at maturity: | If worst performing asset finishes at or above its downside threshold level, par; otherwise, 1% loss for every 1% that worst performing asset declines from initial level
|
| Call option: | At par on any semiannual determination date
|
| Initial levels: | 3,693.23 for S&P 500, $76.65 for SPDR S&P Biotech ETF
|
| Downside thresholds: | 2,215.938 for S&P 500, $45.99 for SPDR S&P Biotech ETF, 60% of initial level
|
| Pricing date: | Sept. 23
|
| Settlement date: | Sept. 28
|
| Agent: | J.P. Morgan Securities LLC
|
| Fees: | 0%
|
|
|
| Cusip: | 48133M6Z8
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
